What are the differences between sinus Wolff‑Parkinson‑White (WPW) and antidromic Wolff‑Parkinson‑White (WPW)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sinus WPW vs. Antidromic WPW: Key Differences

Sinus WPW refers to the baseline ECG pattern during normal sinus rhythm showing ventricular pre-excitation (delta wave, short PR interval, wide QRS), while antidromic WPW is a specific type of reentrant tachycardia where the accessory pathway conducts anterogradely from atrium to ventricle and the AV node conducts retrogradely, producing a wide QRS tachycardia. 1

Sinus WPW (Pre-excitation Pattern)

Electrical Pathway and ECG Features:

  • During sinus rhythm, the accessory pathway conducts anterogradely in parallel with the AV node, creating fusion between pre-excited ventricular activation and normal AV nodal conduction 1
  • The ECG demonstrates three characteristic features: (1) PR interval <120 ms, (2) delta wave (slurring of initial QRS upstroke), and (3) widened QRS complex >120 ms 1, 2
  • The degree of pre-excitation varies based on the relative contribution of conduction through the accessory pathway versus the AV node 3
  • This represents a manifest accessory pathway that conducts anterogradely, affecting the resting ECG 1

Clinical Context:

  • Occurs in 0.1% to 0.3% of the general population 1
  • May be asymptomatic (isolated pre-excitation) or symptomatic (WPW syndrome when associated with documented arrhythmias) 1
  • The pattern itself is not a tachycardia—it is the baseline ECG appearance during normal sinus rhythm 3

Antidromic AVRT (Antidromic WPW)

Electrical Pathway and Mechanism:

  • This is a reentrant tachycardia where the circuit uses the accessory pathway for anterograde conduction (atrium to ventricle) and the AV node for retrograde conduction (ventricle to atrium) 1
  • Rarely, a second accessory pathway may serve as the retrograde limb instead of the AV node, termed "pre-excited AVRT" 1
  • The reentrant circuit requires both the accessory pathway and the AV node (or second pathway) to sustain the tachycardia 1

ECG Characteristics During Tachycardia:

  • Produces a wide QRS complex tachycardia with maximal pre-excitation because ventricular activation occurs entirely through the accessory pathway 1
  • The QRS morphology differs from sinus WPW because there is no fusion with normal AV nodal conduction—all ventricular activation is via the accessory pathway 3
  • Can be difficult to distinguish from ventricular tachycardia on surface ECG due to the wide QRS morphology 4

Clinical Significance:

  • Accounts for only 5% to 10% of tachycardia episodes in patients with manifest accessory pathways, making it much less common than orthodromic AVRT (which accounts for 90-95% of episodes) 1, 4
  • Left lateral pathways are more frequently associated with antidromic AVRT, while septal locations are less common 4
  • Clinically documented in less than 5% of WPW patients and inducible in less than 10% during electrophysiology studies 4

Critical Distinction for Clinical Management

Why This Matters:

  • Sinus WPW is a baseline ECG finding that may or may not cause symptoms; management focuses on risk stratification for sudden cardiac death based on accessory pathway properties 1
  • Antidromic AVRT is an active tachyarrhythmia requiring acute termination and consideration for definitive catheter ablation 1

Acute Management Differs:

  • For antidromic AVRT in hemodynamically unstable patients, immediate synchronized cardioversion is indicated (Class I) 1
  • For stable antidromic AVRT, intravenous procainamide or ibutilide is recommended as first-line pharmacologic therapy 1, 5
  • AV nodal blocking agents (adenosine, beta-blockers, calcium channel blockers, digoxin) are absolutely contraindicated in antidromic AVRT and pre-excited atrial fibrillation because they can precipitate ventricular fibrillation by blocking the AV node while allowing unopposed rapid conduction through the accessory pathway 1, 5

Common Pitfall:

  • Clinicians may confuse the wide QRS complex of antidromic AVRT with ventricular tachycardia, potentially leading to inappropriate treatment decisions 4
  • The term "antidromic WPW" is sometimes incorrectly used to describe any wide QRS tachycardia in a WPW patient, but it specifically refers to this reentrant mechanism using the accessory pathway anterogradely 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Wolff-Parkinson-White Syndrome: Diagnosis and Risk Stratification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Monitoring and Management of Wolff-Parkinson-White Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.